Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marouan Rami"'
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 224-229 (2019)
Using histamine as lead molecule, a library of (hetero)aryl substituted thiazol-2,4-yl derivatives incorporating pyridine as proton shuttling moiety were obtained and investigated as activators of human carbonic anhydrase (CA, EC 4.2.1.1) isoforms I,
Externí odkaz:
https://doaj.org/article/e55317ea4e174352b997ce004b41d544
Autor:
Marouan Rami, Elodie Landagaray, Mohamed Ettaoussi, Koussayla Boukhalfa, Daniel-Henri Caignard, Philippe Delagrange, Pascal Berthelot, Saïd Yous
Publikováno v:
Molecules, Vol 18, Iss 1, Pp 154-166 (2012)
Novel conformationally restricted analogues of agomelatine were synthesized and pharmacologically evaluated at MT1 and MT2 melatoninergic receptors. Replacement of the N-acetyl side chain of agomelatine by oxathiadiazole-2-oxide (compound 3), oxadiaz
Externí odkaz:
https://doaj.org/article/3fa69f31d62e4ce099364a299d851be9
Autor:
Romain, Duroux, Marouan, Rami, Elodie, Landagaray, Mohamed, Ettaoussi, Daniel-Henri, Caignard, Philippe, Delagrange, Patricia, Melnyk, Saïd, Yous
Publikováno v:
European journal of medicinal chemistry. 141
We recently reported a series of naphthofuranic compounds as constrained agomelatine analogues. Herein, in order to explore alternative ethyl amide side chain rigidification, naphthocyclopentane and quinolinocyclopentane derivatives with various acet
Autor:
Elodie Landagaray, Daniel-Henri Caignard, Pascal Berthelot, Patricia Melnyk, Marouan Rami, Saïd Yous, Jean A. Boutin, Mohamed Ettaoussi, Philippe Delagrange
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2017, 127, pp.621-631. ⟨10.1016/j.ejmech.2016.12.013⟩
European Journal of Medicinal Chemistry, 2017, 127, pp.621-631. ⟨10.1016/j.ejmech.2016.12.013⟩
European Journal of Medicinal Chemistry, Elsevier, 2017, 127, pp.621-631. ⟨10.1016/j.ejmech.2016.12.013⟩
European Journal of Medicinal Chemistry, 2017, 127, pp.621-631. ⟨10.1016/j.ejmech.2016.12.013⟩
New series of melatonergic ligands issued from two methoxy-quinolinic scaffolds (2-MQ and 3-MQ), were designed and synthesized. Herein we report the synthetic scheme and pharmacological results of the new prepared compounds. Investigation of compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eff324fee630435dee54dfde56bcd365
https://hal.archives-ouvertes.fr/hal-02060568
https://hal.archives-ouvertes.fr/hal-02060568
Autor:
Marouan Rami, Jean-Yves Winum, Philippe Lambin, Simona Maria Monti, Ludwig Dubois, Giuseppina De Simone, Nanda-Kumar Parvathaneni, Vincenzo Alterio, Claudiu T. Supuran, Simon J. A. van Kuijk
Publikováno v:
Journal of Medicinal Chemistry, 56(21), 8512-8520. American Chemical Society
Journal of Medicinal Chemistry; Vol 56
Journal of medicinal chemistry (Online) 56 (2013): 8512–8520. doi:10.1021/jm4009532
info:cnr-pdr/source/autori:Rami M.; Dubois L.; Parvathaneni N.-K.; Alterio V.; Van Kuijk S.J.A.; Monti S.M.; Lambin P.; De Simone G.; Supuran C.T.; Winum J.-Y./titolo:Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides%2Fsulfamides%2Fsulfamates/doi:10.1021%2Fjm4009532/rivista:Journal of medicinal chemistry (Online)/anno:2013/pagina_da:8512/pagina_a:8520/intervallo_pagine:8512–8520/volume:56
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry; Vol 56
Journal of medicinal chemistry (Online) 56 (2013): 8512–8520. doi:10.1021/jm4009532
info:cnr-pdr/source/autori:Rami M.; Dubois L.; Parvathaneni N.-K.; Alterio V.; Van Kuijk S.J.A.; Monti S.M.; Lambin P.; De Simone G.; Supuran C.T.; Winum J.-Y./titolo:Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides%2Fsulfamides%2Fsulfamates/doi:10.1021%2Fjm4009532/rivista:Journal of medicinal chemistry (Online)/anno:2013/pagina_da:8512/pagina_a:8520/intervallo_pagine:8512–8520/volume:56
Journal of Medicinal Chemistry
A series of nitroimidazoles incorporating sulfonamide/sulfamide/sulfamate moieties were designed and synthesized as radio/chemosensitizing agent targeting the tumor-associated carbonic anhydrase (CA) isoforms IX and XII. Most of the new compounds wer
Autor:
Marc Vooijs, Claudiu T. Supuran, Jean-Yves Winum, Ruchi Saraya, Nanda Kumar Parvathaneni, Marouan Rami, Simon J. A. van Kuijk, Daniela Vullo, R. Biemans, Ala Yaromina, Philippe Lambin, S. Peeters, Natasja G. Lieuwes, Ludwig Dubois
Publikováno v:
Radiotherapy and Oncology; Vol 108
Radiotherapy and Oncology, 108(3), 523-528. Elsevier Ireland Ltd
Radiotherapy and Oncology
Radiotherapy and Oncology, 108(3), 523-528. Elsevier Ireland Ltd
Radiotherapy and Oncology
Background and purpose Carbonic anhydrase IX (CAIX) plays an important role in pH regulation processes critical for tumor cell growth and metastasis. We hypothesize that a dual targeting bioreductive nitroimidazole based anti-CAIX sulfamide drug (DH3
Autor:
Mohamed Ettaoussi, Philippe Delagrange, Jean A. Boutin, Pierre Renard, Ahmed Sabaouni, Pascal Berthelot, Michael Spedding, Marouan Rami, Saïd Yous, Daniel-Henri Caignard
Publikováno v:
European Journal of Medicinal Chemistry. 49:310-323
As part of our ongoing interest in developing new melatoninergic ligands bearing the same pharmacological profile as agomelatine, we focused our attention on this compound as a lead. Several chemical modifications have been performed on positions C-3
Autor:
Saïd Yous, Pierre Renard, Mohamed Ettaoussi, Pascal Berthelot, Marouan Rami, Jean A. Boutin, Daniel-Henri Caignard, Veronique Leclerc, Philippe Delagrange, Amaury Farce
Publikováno v:
European Journal of Medicinal Chemistry. 46:1622-1629
Naphthalenic analogs of MCA-NAT (5-methoxycarbonylamino-N-acetyltryptamine) have been synthesized and evaluated as melatonin receptor ligands. Introduction of a methoxycarbonylamino substituent at the C-7 position of the naphthalenic nucleus yields M
Autor:
Alfonso Maresca, Andrea Scozzafava, Claudiu T. Supuran, Fatma-Zhora Smaine, Jean-Louis Montero, Marouan Rami, Jean-Yves Winum
Publikováno v:
Bioorganic & Medicinal Chemistry Letters; Vol 21
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2011, 21, pp.2975-2979. ⟨10.1016/j.bmcl.2011.03.055⟩
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2011, 21, pp.2975-2979. ⟨10.1016/j.bmcl.2011.03.055⟩
A new series of sulfonamides was synthesized by the reaction of the boroxazolidone complex of l-lysine with isothiocyanates incorporating sulfamoyl moieties and diverse organic scaffolds. The obtained thioureas have been investigated as inhibitors of
Autor:
Mohamed Ettaoussi, Philippe Delagrange, Daniel-Henri Caignard, Marouan Rami, Elodie Landagaray, Saïd Yous, Koussayla Boukhalfa, Pascal Berthelot
Publikováno v:
Molecules
Molecules; Volume 18; Issue 1; Pages: 154-166
Molecules, Vol 18, Iss 1, Pp 154-166 (2012)
Molecules; Volume 18; Issue 1; Pages: 154-166
Molecules, Vol 18, Iss 1, Pp 154-166 (2012)
Novel conformationally restricted analogues of agomelatine were synthesized and pharmacologically evaluated at MT1 and MT2 melatoninergic receptors. Replacement of the N-acetyl side chain of agomelatine by oxathiadiazole-2-oxide (compound 3), oxadiaz